Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Messoud Ashina

Showing results (1-10 of 431) with videos related to

Pageof 44
Sort By:
The Lancet. Neurology|December 20, 2018
The most important advances in headache research in 2018Messoud Ashina
CNS & Neurological Disorders Drug Targets|August 19, 2007
Pathophysiology of tension-type headache: potential drug targetsMessoud Ashina
Expert Opinion on Pharmacotherapy|April 6, 2002
Nitric oxide synthase inhibitors for the treatment of chronic tension-type headacheMessoud Ashina
Brain : a Journal of Neurology|August 27, 2022
Targeting enkephalins and pituitary adenylate cyclase-activating polypeptide (PACAP) in migraineMessoud Ashina
Cephalalgia : an International Journal of Headache|April 24, 2012
Vascular changes have a primary role in migraineMessoud Ashina
Cephalalgia : an International Journal of Headache|October 4, 2019
Board Walk - October 2019Messoud Ashina
The New England Journal of Medicine|November 19, 2020
MigraineMessoud Ashina
Cephalalgia : an International Journal of Headache|July 19, 2021
Board Walk - August 2021Messoud Ashina
Current Pain and Headache Reports|November 8, 2003
Current and potential future drug therapies for tension-type headacheSait Ashina, Messoud Ashina
The Journal of Headache and Pain|May 10, 2018
Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?Messoud Ashina, Paolo Martelletti
Pageof 44

Showing results (1-10 of 431) with videos related to

Sort By:
Pageof 44
The Lancet. Neurology|December 20, 2018
The most important advances in headache research in 2018Messoud Ashina
CNS & Neurological Disorders Drug Targets|August 19, 2007
Pathophysiology of tension-type headache: potential drug targetsMessoud Ashina
Expert Opinion on Pharmacotherapy|April 6, 2002
Nitric oxide synthase inhibitors for the treatment of chronic tension-type headacheMessoud Ashina
Brain : a Journal of Neurology|August 27, 2022
Targeting enkephalins and pituitary adenylate cyclase-activating polypeptide (PACAP) in migraineMessoud Ashina
Cephalalgia : an International Journal of Headache|April 24, 2012
Vascular changes have a primary role in migraineMessoud Ashina
Cephalalgia : an International Journal of Headache|October 4, 2019
Board Walk - October 2019Messoud Ashina
The New England Journal of Medicine|November 19, 2020
MigraineMessoud Ashina
Cephalalgia : an International Journal of Headache|July 19, 2021
Board Walk - August 2021Messoud Ashina
Current Pain and Headache Reports|November 8, 2003
Current and potential future drug therapies for tension-type headacheSait Ashina, Messoud Ashina
The Journal of Headache and Pain|May 10, 2018
Pituitary adenylate-cyclase-activating polypeptide (PACAP): another novel target for treatment of primary headaches?Messoud Ashina, Paolo Martelletti
Pageof 44